Nasdaq IPOs

Vallon Pharmaceuticals, a biopharmaceutical company developing abuse-deterrent prescription drugs for CNS disorders, filed on Friday with the SEC to raise up to $17 million in an initial public offering. The company's clinical-stage product currently under development is Abuse-D

TS Innovation Acquisitions, a blank check company formed by Tishman Speyer targeting the real estate industry, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 millio

Eucrates Biomedical Acquisition, a blank check company formed by Vedanta Management targeting data-driven healthcare and biotech businesses, raised $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exerci

Acies Acquisition, a blank check company targeting live, location-based, and mobile experiential entertainment, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The company

Foghorn Therapeutics, a preclinical biotech developing gene therapies for hematologic cancers and solid tumors, raised $120 million by offering 7.5 million shares at $16, within the range of $15 to $17. At pricing, the company commands a fully diluted market value of $628 million

Altimar Acquisition, a blank check company formed by HPS Investment Partners, raised $250 million by offering 25 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The company originally planned to offer 30 mil

Zanite Acquisition, a blank check company formed by Resilience Capital and Directional Aviation, filed on Thursday with the SEC to raise up to $200 million in an initial public offering. The Cleveland, OH-based company plans to raise $200 million by offering 20 million units at

Mallard Acquisition, a blank check company formed by Mallard Capital targeting an industrials business, raised the proposed deal size for its upcoming IPO on Thursday. The Cornelius, NC-based company now plans to raise $110 million by offering 11 million units at a price of $10.

Lufax Holding, which provides a leading platform for retail loan facilitation in China, announced terms for its IPO on Thursday. The Shanghai, China-based company plans to raise $2.2 billion by offering 175 million ADSs at a price range of $11.50 to $13.50. At the midpoint of th

Churchill Capital Corp V, the fifth blank check company founded by dealmaker and former Citi executive Michael Klein, raised the proposed deal size for its upcoming IPO on Thursday. The New York, NY-based company now plans to raise $400 million by offering 40 million units at a

New Beginnings Acquisition, a blank check company formed by the co-founder of Crescent Heights and an executive from Alliant Insurance Services, raised the proposed deal size for its upcoming IPO on Thursday. The Miami, FL-based company now plans to raise $100 million by offerin

G Medical Innovations Holdings, which provides app-connected medical devices for monitoring vital signs, launched its IPO on Thursday. The company was previously listed on the ASX (GMV) but recently delisted its shares. It had previously filed for a US IPO in May 2019 but wi

G Medical Innovations Holdings, which provides app-connected medical devices for monitoring vital signs, announced terms for its IPO on Thursday. The company was previously listed on the ASX (GMV) but recently delisted its shares. It had previously filed for a US IPO in May

Leslie's, a leading US provider of pool supplies and services with over 930 retail locations, announced terms for its IPO on Thursday. The Phoenix, AZ-based company plans to raise $600 million by offering 40 million shares (25% insider) at a price range of $14 to $16. New invest

Galecto, a Phase 2 biotech developing therapeutics for fibrosis and related diseases, announced terms for its IPO on Thursday. The Copenhagen, Denmark-based company plans to raise $85 million by offering 5.7 million shares at a price range of $14 to $16. At the midpoint of the p

Abcam, which sells biological reagents and tools for research, drug discovery, and diagnostics, raised $157 million by offering 8.9 million ADSs at $17.50, below the as-converted last close of $18.06 for its shares trading on the AIM (ABC). At pricing, the company raised 6% more

Abcam, which sells biological reagents and tools for research, drug discovery, and diagnostics, raised $157 million by offering 8.9 million ADSs at $17.50, below the as-converted last close of its shares on the AIM (ABC). At pricing, the company raised 6% more in proceeds than an

Rice Acquisition, a blank check company formed by Rice Investment Group targeting energy transition and the sustainability arena, raised $215 million by offering 21.5 million units at $10. The company offered 1.5 million more units than anticipated. Each unit consists of one

Yellowstone Acquisition, a blank check company formed by Boston Omaha Corp. targeting the financial and real estate sectors, raised $125 million by offering 12.5 million units at $10. The company offered 2.5 million fewer units than anticipated. Each unit consists of one share of

Cerberus Telecom Acquisition, a blank check company formed by Cerberus Capital Management targeting the ICT industry, raised $250 million by offering 25 million units at $10. The company offered 5 million fewer units than anticipated. Each unit consists of one share of common sto